Inventor · disambiguated record
Graham Carter
Also filed as: CARTER GRAHAM
12 granted patents·14 pending applications·239 citations·filing 1973–2008
91Inventor score
Top patents by PatentIndex Score
26 records- 0194US7125689B2Method for rendering streptokinase less immunogenic to a humanBIOVATION LTD·Filed 2002·Granted Oct 24, 2006·67 cites·1 claims
- 0291US7189830B2Anti-KSA/IL-2 fusion proteins with reduced immunogenicityMERCK PATENT GMBH·Filed 2002·Granted Mar 13, 2007·29 cites·1 claims
- 0391US7132511B2Modified anti-EGFR antibodies with reduced immunogenicityMERCK PATENT GMBH·Filed 2002·Granted Nov 7, 2006·46 cites·3 claims
- 0489US7430476B2Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicityMERCK PATENT GMBH·Filed 2002·Granted Sep 30, 2008·24 cites·5 claims
- 0587US7465572B2De-immunized streptokinaseMERCK PATENT GMBH·Filed 2006·Granted Dec 16, 2008·4 cites·2 claims
- 0687US4014676AWater treatment for controlling the growth of algae employing biguanidesICI LTD·Filed 1973·Granted Mar 29, 1977·35 cites·3 claims
- 0784US7381795B2Modified interferon beta with reduced immunogenicityMERCK PATENT GMBH·Filed 2002·Granted Jun 3, 2008·9 cites·3 claims
- 0881US7615217B2Artificial proteins with reduced immunogenicityMERCK PATENT GMBH·Filed 2007·Granted Nov 10, 2009·3 cites·6 claims
- 0981US6927025B1Methods for protein screeningBIOVATION LTD·Filed 2000·Granted Aug 9, 2005·21 cites·8 claims
- 1070US7939295B2Methods for reducing immunogenicity of polypeptidesMERCK PATENT GMBH·Filed 2002·Granted May 10, 2011·1 cites·3 claims
- 1163US7615615B2Modified interferon beta with reduced immunogenicityMERCK PATENT GMBH·Filed 2008·Granted Nov 10, 2009·0 cites·7 claims
- 1251US2005222392A1Anti-idiotype anti-cea antibody molecules and its use as cancer vaccineCARTER GRAHAM·Filed 2003·Application pending·0 cites
- 1348US2005181459A1Method for mapping and eliminating T cell epitopesFiled 2004·Application pending·0 cites
- 1448US2004071688A1Modified thrombopoietin with reduced immunogenicityFiled 2002·Application pending·0 cites
- 1547US2004087503A1Modified ciliary neurotrophic factor (cntf ) with reduced immunogenicityFiled 2002·Application pending·0 cites
- 1647US2006062761A1Modified interferon alpha with reduced immunogenicityCARR FRANCIS J·Filed 2002·Application pending·0 cites
- 1744US2005240009A1T-cell epitopes in staphylococcal enterotoxin bCARR FRANCIS J·Filed 2003·Application pending·0 cites
- 1842US2005020494A1Modified human growth hormoneFiled 2002·Application pending·0 cites
- 1942US2004254106A1Modified factor ixFiled 2002·Application pending·0 cites
- 2041US7392141B2Method of preparing a modified granulocyte colony stimulating factor (G-CSF) with reduced immunogenicityMERCK PATENT GMBH·Filed 2002·Granted Jun 24, 2008·0 cites·1 claims
- 2141US2004121443A1Modified protamine with reduced immunogenicityFiled 2002·Application pending·0 cites
- 2240US2004076991A1Modified interleukin-1 receptor antagonist(il-1ra) with reduced immunogenicityFiled 2002·Application pending·0 cites
- 2340US2004096459A1Modified insulin with reduced immunogenicityFiled 2002·Application pending·0 cites
- 2440US2004072219A1Modified leptin with reduced immunogenicityFiled 2002·Application pending·0 cites
- 2540US2004072291A1Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicityFiled 2002·Application pending·0 cites
- 2639US2003171290A1Peptides presented by cellsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →